GlassScriptPhysician profile
Theresa Lorch
NPI 1104888122
$3,087.27
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $506 · 2021: $202 · 2022: $309 · 2023: $547 · 2024: $34.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $622.05 | 2019-2023 | Farxiga, Breztri |
| Lilly USA, LLC | $518.24 | 2019-2023 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $385.57 | 2019-2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $236.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $216.53 | 2019-2021 | |
| Pfizer INC. | $184.72 | 2019-2023 | |
| Glaxosmithkline, LLC. | $148.61 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.38 | 2019-2023 | Jardiance |
| Abbvie INC. | $106.42 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $91.03 | 2019-2024 | |
| Hikma Pharmaceuticals USA | $64.52 | 2019-2020 | |
| Amgen INC. | $63.82 | 2019-2023 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.21 | 2019 | |
| Amarin Pharma, INC. | $35.29 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $31.29 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $30.24 | 2019-2020 | |
| Sanofi Pasteur INC. | $29.49 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $23.29 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.98 | 2019 | |
| Eisai INC. | $21.44 | 2021 | |
| Exact Sciences Corporation | $18.31 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $18.08 | 2022 | |
| Medtronic, INC. | $14.75 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.75 | 2023 | |
| Horizon Therapeutics Plc | $13.03 | 2020 | |
| Endo Pharmaceuticals INC. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Lorch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.